Nowe cele terapii ukierunkowanej w nowotworach układu chłonnego z perspektywy ostatnich 5 lat badań
Hematologia · 2015
DOI: 10.5603/hem.2015.0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematologia, 2015. Verfasst von Przemysław Juszczyński. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Translational studies on lymphoid malignancies have been, over the last 5 years, particularly intriguing and productive/fruitful. New discoveries have been fuelled by new technological research platforms, increasing computational powers, advances in bioinformatics and increasing academic-biotech/pharmaceutical partnerships. In some cases, this has led to vital advances in clinical practice where discoveries in epigenetic mechanisms were particularly significant in the regulation of human genome function, B-cell receptor signalling and tumour-associated immune escape mechanisms. It is very likely that the translational potential of these findings will thus be further developed in the future.
Zitieren
APA
Juszczyński, P. (2015). Nowe cele terapii ukierunkowanej w nowotworach układu chłonnego z perspektywy ostatnich 5 lat badań. Hematologia. https://doi.org/10.5603/hem.2015.0010
Vancouver
Juszczyński P. Nowe cele terapii ukierunkowanej w nowotworach układu chłonnego z perspektywy ostatnich 5 lat badań. Hematologia. 2015. doi:10.5603/hem.2015.0010
BibTeX
@article{Juszczyski2015,
author = {Juszczyński, Przemysław},
title = {Nowe cele terapii ukierunkowanej w nowotworach układu chłonnego z perspektywy ostatnich 5 lat badań},
journal = {Hematologia},
year = {2015},
doi = {10.5603/hem.2015.0010}
}
EUVIMED